NPHS1 and Hypoalbuminemia: Moreover, in order to develop an assay for large-scale screening of therapeutic agents to treat the GFB defects, we showed the feasibility to use fluorescence-based measurement of intravascular protein abundance to examine the hypoalbuminemia-like phenotype due to the defective GFB in the nphs1 mutants.